CHMP5 and neoplasm: The presence of pre-existing immunity against the spike protein, local inflammatory responses, reprogramming of the immune suppressive TME, and elevated antigen presentation activity were all prerequisites for more rapid, potent, and extensive tumor-targeting T cell responses.